OLAYEMI FALAYI: Open Payments
NPI 1740500321 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,600 in 59 payments from 7 companies in 2025. Trend: 2023 $1,413 · 2024 $1,408 · 2025 $1,600
Food & beverage: $1,600
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 23 | $715 |
| ViiV Healthcare Company | 11 | $386 |
| ABBVIE INC. | 12 | $189 |
| Exact Sciences Corporation | 7 | $186 |
| Merck Sharp & Dohme LLC | 2 | $55 |
| Napo Pharmaceuticals Inc | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
Products named: Epclusa, CABENUVA, Cologuard Collection Kit, VRAYLAR, Yeztugo, APRETUDE, DOVATO, PIFELTRO.
Industry payments across OH — which companies pay providers there.
